NO177591C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Info

Publication number
NO177591C
NO177591C NO911200A NO911200A NO177591C NO 177591 C NO177591 C NO 177591C NO 911200 A NO911200 A NO 911200A NO 911200 A NO911200 A NO 911200A NO 177591 C NO177591 C NO 177591C
Authority
NO
Norway
Prior art keywords
therapeutically active
adenosine receptor
analogous process
selective adenosine
receptor agents
Prior art date
Application number
NO911200A
Other languages
English (en)
Norwegian (no)
Other versions
NO177591B (no
NO911200L (no
NO911200D0 (no
Inventor
Norton Paul Peet
Nelson Lowell Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911200D0 publication Critical patent/NO911200D0/no
Publication of NO911200L publication Critical patent/NO911200L/no
Publication of NO177591B publication Critical patent/NO177591B/no
Publication of NO177591C publication Critical patent/NO177591C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (4)

Publication Number Publication Date
NO911200D0 NO911200D0 (no) 1991-03-25
NO911200L NO911200L (no) 1991-09-27
NO177591B NO177591B (no) 1995-07-10
NO177591C true NO177591C (no) 1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911200A NO177591C (no) 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country Link
US (1) US5047534A (de)
EP (1) EP0449175B1 (de)
JP (1) JP3181305B2 (de)
KR (1) KR100195368B1 (de)
CN (1) CN1032815C (de)
AR (1) AR247887A1 (de)
AT (1) ATE156130T1 (de)
AU (1) AU632914B2 (de)
CA (1) CA2038747C (de)
DE (1) DE69127010T2 (de)
DK (1) DK0449175T3 (de)
ES (1) ES2107431T3 (de)
FI (1) FI98461C (de)
GR (1) GR3025135T3 (de)
HU (1) HU208824B (de)
IE (1) IE910982A1 (de)
IL (1) IL97656A (de)
NO (1) NO177591C (de)
NZ (1) NZ237484A (de)
PH (1) PH27511A (de)
PT (1) PT97133B (de)
ZA (1) ZA912038B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
US5840729A (en) * 1993-02-26 1998-11-24 Merrell Pharmaceuticals Inc. Xanthine derivatives as adenosine A1 receptor antagonists
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
CN1043473C (zh) * 1993-05-06 1999-05-26 默里尔多药物公司 8位取代黄嘌呤作为选择性腺苷受体药物
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
CN1787821A (zh) * 2003-06-10 2006-06-14 协和发酵工业株式会社 一种治疗焦虑症的方法
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung

Also Published As

Publication number Publication date
NO177591B (no) 1995-07-10
IL97656A (en) 1996-06-18
FI98461C (fi) 1997-06-25
NZ237484A (en) 1993-10-26
CN1055181A (zh) 1991-10-09
CN1032815C (zh) 1996-09-18
FI98461B (fi) 1997-03-14
ZA912038B (en) 1991-12-24
PT97133B (pt) 1998-07-31
HUT56570A (en) 1991-09-30
DE69127010D1 (de) 1997-09-04
AR247887A1 (es) 1995-04-28
DK0449175T3 (da) 1998-02-23
DE69127010T2 (de) 1997-11-13
NO911200L (no) 1991-09-27
CA2038747C (en) 2002-05-28
AU632914B2 (en) 1993-01-14
CA2038747A1 (en) 1991-09-27
KR910016752A (ko) 1991-11-05
FI911420A0 (fi) 1991-03-25
EP0449175B1 (de) 1997-07-30
IE910982A1 (en) 1991-10-09
JPH04221384A (ja) 1992-08-11
ATE156130T1 (de) 1997-08-15
FI911420A (fi) 1991-09-27
ES2107431T3 (es) 1997-12-01
EP0449175A3 (en) 1993-01-20
PH27511A (en) 1993-08-18
US5047534A (en) 1991-09-10
HU208824B (en) 1994-01-28
IL97656A0 (en) 1992-06-21
NO911200D0 (no) 1991-03-25
JP3181305B2 (ja) 2001-07-03
AU7353791A (en) 1991-10-03
KR100195368B1 (ko) 1999-06-15
EP0449175A2 (de) 1991-10-02
GR3025135T3 (en) 1998-02-27
PT97133A (pt) 1991-12-31

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
ZA909141B (en) Therapeutically active chloro substituted benzimidazoles,processes for their preparation as well as their use
NL192986B (nl) Werkwijze voor het bereiden van 1,4-dihydro-4-oxo-naftyridinederivaten.
NO179908C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, carbocykliske adenosinanaloger
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
NO177591C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175781C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
KR950700252A (ko) 피브리노겐 수용체 길항제를 제조하는 방법(Process for preparing fibrinogen receptor antagonists)
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
NO178624C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-substituerte alkyl-3-karboksy-karbapenemer
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
NO177099C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive steroidderivater
NO179367C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser
FI910448A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
ATE111466T1 (de) Selektive adenosinrezeptor-verbindungen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003